Lynette Rogers to Bronchopulmonary Dysplasia
This is a "connection" page, showing publications Lynette Rogers has written about Bronchopulmonary Dysplasia.
Connection Strength
2.371
-
Alterations in VASP phosphorylation and profilin1 and cofilin1 expression in hyperoxic lung injury and BPD. Respir Res. 2018 Nov 21; 19(1):229.
Score: 0.620
-
Attenuation of miR-17~92 Cluster in Bronchopulmonary Dysplasia. Ann Am Thorac Soc. 2015 Oct; 12(10):1506-13.
Score: 0.498
-
Plasma lipid metabolites are associated with gestational age but not bronchopulmonary dysplasia. Acta Paediatr. 2012 Aug; 101(8):e321-6.
Score: 0.393
-
Alterations of the thioredoxin system by hyperoxia: implications for alveolar development. Am J Respir Cell Mol Biol. 2009 Nov; 41(5):612-9.
Score: 0.315
-
Thioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental Bronchopulmonary Dysplasia. Oxid Med Cell Longev. 2019; 2019:7945983.
Score: 0.157
-
Aurothioglucose does not improve alveolarization or elicit sustained Nrf2 activation in C57BL/6 models of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2018 05 01; 314(5):L736-L742.
Score: 0.146
-
Of mice and men: correlations between microRNA-17~92 cluster expression and promoter methylation in severe bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2016 Nov 01; 311(5):L981-L984.
Score: 0.134
-
Neonatal hyperoxic exposure persistently alters lung secretoglobins and annexin A1. Biomed Res Int. 2013; 2013:408485.
Score: 0.108